Stroke · 2017 · 228 citations · 29 references
These results indicate that the NLRP3 inflammasome inhibitor, MCC950, attenuates brain injury and inflammation after ICH. Hence, NLRP3 inflammasome inhibition is a potential therapy for ICH that warrants further investigation.
29
Monica R. P. Elmore, Allison R. Najafi, Maya A. Koike et al. · Neuron · 2014 · 1.9K citations · Full text
Inflammation, Neuroregeneration, Neurobiology Of Disease +12
J Chen, Paul R. Sanberg, Y Li et al. · Stroke · 2001 · 1.3K citations · Full text
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Jean M. Daley, Alan Thomay, Michael D. Connolly et al. · Journal of Leukocyte Biology · 2007 · 1K citations
Konstantin Prass, Christian Meisel, Conny Höflich et al. · The Journal of Experimental Medicine · 2003 · 890 citations · Full text